Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Expert Review of Anticancer Therapy|September 21, 2011
Choosing first-line therapy for chronic lymphocytic leukemiaSamantha Jaglowski, Jeffrey A Jones
Current Problems in Cancer|January 11, 2022
CAR T-cell therapy for B-cell lymphomaNathan Denlinger, David Bond, Samantha Jaglowski
Clinical Lymphoma, Myeloma & Leukemia|April 20, 2024
SOHO State of the Art Updates and Next Questions Updates on Building Your CAR-T Cell ProgramTimothy J Voorhees, Evandro Bezerra, Nathan Denlinger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 28, 2020
Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best PracticesMonica Ardura, David Hartley, Christopher Dandoy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 10, 2019
Carfilzomib for Treatment of Refractory Chronic Graft-versus-Host Disease: A Chronic GVHD Consortium Pilot Phase II TrialJoseph Pidala, Samantha Jaglowski, Annie Im, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 20, 2014
Aprepitant for the control of delayed nausea and vomiting associated with the use of high-dose melphalan for autologous peripheral blood stem cell transplants in patients with multiple myeloma: a phase II studyThomas Bechtel, Ali McBride, Brooke Crawford, et al.
Blood|October 31, 2014
A phase 1/1b study of rituximab, bendamustine, and ibrutinib in patients with untreated and relapsed/refractory non-Hodgkin lymphomaKami Maddocks, Beth Christian, Samantha Jaglowski, et al.
Transplantation and Cellular Therapy|October 1, 2020
Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter AnalysisAdam S Kittai, Ying Huang, Max Gordon, et al.
Journal of Geriatric Oncology|August 29, 2020
Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignanciesJordon L Jaggers, Smith Giri, Heidi D Klepin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2019
Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell TransplantationHassan Issa, Nidhi Sharma, Qiuhong Zhao, et al.
Pageof 8